Validation of Immunohistochemistry for Identification of IDH1 Mutation in Gliomas

被引：0
|
作者：
Egoavil, C. M.
Paya, A.
Irles, E.
Garcia-Martinez, A.
Soto, J. L.
Castillejo, A.
Castillejo, M. I.
Quintanar, T.
Herrero, J.
Rodriguez-Lescure, A.
Portugues, M. J.
Moreno, P.
Heredia, L.
Andrada, E.
Aranda, I.
Barbera, V. M.
Alenda, C.
机构：
[1] Univ Hosp HGUA, Alicante, Spain
[2] Univ Hosp HGUE, Alicante, Spain
[3] HGUE, Alicante, Spain
[4] HGUA, Alicante, Spain
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1974
引用
收藏
页码：474A / 474A
页数：1
相关论文
共 50 条
  • [21] Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies
    Ikota, Hayato
    Nobusawa, Sumihito
    Arai, Hideo
    Kato, Yukinari
    Ishizawa, Keisuke
    Hirose, Takanori
    Yokoo, Hideaki
    BRAIN TUMOR PATHOLOGY, 2015, 32 (04) : 237 - 244
  • [22] Molecular signatures classify astrocytic gliomas by IDH1 mutation status
    Toedt, Grischa
    Barbus, Sebastian
    Wolter, Marietta
    Felsberg, Joeg
    Tews, Bjoern
    Blond, Frederic
    Sabel, Michael C.
    Hofmann, Stefanie
    Becker, Natalia
    Hartmann, Christian
    Ohgaki, Hiroko
    von Deimling, Andreas
    Wiestler, Otmar D.
    Hahn, Meinhard
    Lichter, Peter
    Reifenberger, Guido
    Radlwimmer, Bernhard
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (05) : 1095 - 1103
  • [23] Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation
    Shi, Jinlong
    Sun, Baolan
    Shi, Wei
    Zuo, Hao
    Cui, Daming
    Ni, Lanchun
    Chen, Jian
    TUMOR BIOLOGY, 2015, 36 (02) : 655 - 662
  • [24] IDH1 Mutation in Pediatric Gliomas: Has it a Diagnostic and Prognostic Value?
    Buccoliero, Anna Maria
    Castiglione, Francesca
    Degl'Innocenti, Duccio Rossi
    Gheri, Chiara Francesca
    Genitori, Lorenzo
    Taddei, Gian Luigi
    FETAL AND PEDIATRIC PATHOLOGY, 2012, 31 (05) : 278 - 282
  • [25] The Analysis of IDH1 Mutation and MGMT Promoter Methylation in Malignant Gliomas
    Takahashi, Yoshinobu
    Nakamura, Hideo
    Makino, Keishi
    Hide, Takuichirou
    Muta, Daisuke
    Kuratsu, Jun-ichi
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A445 - A445
  • [26] Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies
    Hayato Ikota
    Sumihito Nobusawa
    Hideo Arai
    Yukinari Kato
    Keisuke Ishizawa
    Takanori Hirose
    Hideaki Yokoo
    Brain Tumor Pathology, 2015, 32 : 237 - 244
  • [27] IDH1 mutation of gliomas with long-term survival analysis
    Myung, Jae Kyung
    Cho, Hwa Jin
    Park, Chul-Kee
    Kim, Seung-Ki
    Phi, Ji Hoon
    Park, Sung-Hye
    ONCOLOGY REPORTS, 2012, 28 (05) : 1639 - 1644
  • [28] IDH1 and IDH2 Mutations in Gliomas
    Ducray, Francois
    Marie, Yannick
    Sanson, Marc
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21): : 2248 - 2249
  • [29] IDH1 and IDH2 Mutations in Gliomas
    Adam L. Cohen
    Sheri L. Holmen
    Howard Colman
    Current Neurology and Neuroscience Reports, 2013, 13
  • [30] Mutant IDH1 and thrombosis in gliomas
    Dusten Unruh
    Steven R. Schwarze
    Laith Khoury
    Cheddhi Thomas
    Meijing Wu
    Li Chen
    Rui Chen
    Yinxing Liu
    Margaret A. Schwartz
    Christina Amidei
    Priya Kumthekar
    Carolina G. Benjamin
    Kristine Song
    Caleb Dawson
    Joanne M. Rispoli
    Girish Fatterpekar
    John G. Golfinos
    Douglas Kondziolka
    Matthias Karajannis
    Donato Pacione
    David Zagzag
    Thomas McIntyre
    Matija Snuderl
    Craig Horbinski
    Acta Neuropathologica, 2016, 132 : 917 - 930
12345